The possible relationship between diabetes mellitus and cancer risk has long been discussed (Kessler, 1970 (Kessler, , 1971 Armstrong et al., 1976; Ragozzino et al., 1982; Green & Hougaard, 1984; O'Mara et al., 1985; Levine et al., 1990; Moss et al., 1991; Davey Smith et al., 1992), but there is still a need for quantitative and precise assessment of the risk. This is not surprising, since several studies were based only on anecdotal reports, and most prospective studies of diabetics are based on at most a few hundred cases of all cancers combined (Armstrong et al., 1976; Ragozzino et al., 1982; Green & Hougaard, 1984; Levine et al., 1990; Moss et al., 1991) , thus making any precise inference about specific cancer sites difficult.
The possible relationship between diabetes mellitus and cancer risk has long been discussed (Kessler, 1970 (Kessler, , 1971 Armstrong et al., 1976; Ragozzino et al., 1982 ; Green & Hougaard, 1984; O'Mara et al., 1985; Levine et al., 1990; Moss et al., 1991; Davey Smith et al., 1992) , but there is still a need for quantitative and precise assessment of the risk. This is not surprising, since several studies were based only on anecdotal reports, and most prospective studies of diabetics are based on at most a few hundred cases of all cancers combined (Armstrong et al., 1976; Ragozzino et al., 1982; Green & Hougaard, 1984; Levine et al., 1990; Moss et al., 1991) , thus making any precise inference about specific cancer sites difficult.
The largest data set, and hence the most informative study from the viewpoint of statistical power, was based on 8,220 male and 6,690 female cancer cases and about 5,000 controls admitted to the Roswell Park Memorial Institute between 1957 and 1965 (O'Mara et al., 1985 . In that study, there was a significant risk of endometrial cancer among subjects with a history of diabetes (relative risk, RR 2.0). Significntly elevated nsks of kidney and non-melanomatous skin cancers also emerged in females, but not in males. There was no significnt excess of pancreatic cancer, which however was associated with diabetes mellitus in a few other studies (Kessler, 1970; Wynder et al., 1973; Whittemore et al., 1983; Cuzick & Babiker, 1989) .
It is still not clear whether the association between diabetes and pancreatic cancer, if it exists, implies some aspects of causality, or whether diabetes is only an epiphenomenon of pancreatic cancer. If this is the case, diabetes should arise only shortly before clinical diagnosis of pancreatic cancer.
An association between diabetes and primary liver cancer has also been reported in some studies (Lawson et al., 1986; La Vecchia et al., 1990a; Yu et al., 1991) To provide further quantitative information on the issue, and give a further summary overview of the impact of diabetes on the risk of cancers of several sites, we consider in this article data from a case-control study conducted in Northern Italy.
S and
The data were derived from an ongoing integrated series of case-control studies, based on a network of teaching and general hospitals in the Greater Milan area. Recruitment of cases with cancer of various sites and of the corresponding controls started between 1983 and 1985, and the present report includes data collected until December, 1992.
The general design of this investigation has already been described , and papers on selected cancer sites have already included some information on diabetes (Paramni et al., 1989; Franceschi et al., 1990; La Vecchia et al., 1990a Table I .
Data analhsis and control of confounding Odds ratios, as estimators of relative risks (RRs) of various cancers in subjects with a history of diabetes, together with their 95% confidence intervals (CIs), were first computed from data stratified for age in decades and, when required, sex (Breslow & Day, 1980 Time since diagnosis of diabetes is considered in Table V . For liver and endometrial cancer, the RRs remained elevated up to 10 or more years after diagnosis of diabetes, with risk estimates of 2.6 (95% CI 1.6-4.2) and 2.0 (95% CI 1.4-2.9) respectively, although these estimates were less than those in the first 5 years since diagnosis (RR 3.9 for liver, 3.7 for endometrium). In contrast, for pancreatic cancer the RR declined from 3.2 in the 5 years since diagnosis to 2.3 between 5 and 9 years and to 1.3 (95% CI 0.7-2.3) 10 or more years after diagnosis of diabetes.
Diuscsso
The present analysis of the relationship between diabetes mellitus and the risk of cancer at 19 sites showed no systematic and generalised excess of cancer risk among subjects with diabetes. Significant associations were, however, observed for three cancer sites: liver, pancreas and endometnum. With respect to pancreatic cancer, however, the association was no more evident 10 years or more since diagnosis of diabetes, indicating that it may not be causal. Diabetics were at apparently decreased nrsk of stomach cancer, non-Hodgkin's lymphomas and multiple myeloma. The inverse association with stomach cancer was, at least in the past, explained by allowance for education and body mass index, and that with myeloma was of borderline significance. No plausible explanation, apart from chance or bias, is available for the apparent inverse association with nonHodgkin's lymphomas, particularly since this observation finds little support in previous work on the issue (Ragozzino et al., 1982; O'Mara et al., 1985; Davey Smith et al., 1992) .
Of specific interest in this study scheme was the possibility of systematic comparison of the patterns of risk for different cancer sites with respect to history of diabetes.
Several of the risk estimates were below unity, and this may reflect the increased likelihood of diabetics to be admitted also for acute conditions included in the control group of the present study. The prevalence of diabetes was, however, consistent across diagnostic categories of the controls (5.3% surgical, 4.2% orthopaedic, 5.6% others). Further, even if there is some systematic error in our comparison group, this is unlikely to be large, since the 5.3% estimate of prevalence of diabetics is consistent with estimates from national population-based surveys (ISTAT, 1986) . Other possible sources of bias should be limited, since the hospital-based setting of this study should be optimal as regards the comparability and reliability of the information on disease history (Kelly et al., 1990) . Further, cases and controls were drawn from comparable catchment areas, and the response rate was practically complete.
The pattern of risk for pancreatic cancer is compatible with diabetes being an early sign of the disease -or at least of preneoplastic pancreatic lesion -but the present data lend some support to the possibility of a real association between diabetes and endometrial or liver cancer. For these neoplasms, some decline in the relative risk with time since diagnosis of diabetes was evident, but the risk estimates remained significant for subjects whose diabetes was diagnosed 10 years or more in advance.
Endometrial cancer is strongly associated with obesity, and the consequent increased serum levels and availability of unopposed oestrogen (Siiteri, 1978 (Siiteri, , 1987 Parazzini et al., 1991). Allowance for body mass index, however, only moderately reduced the relative risk for diabetes, the point estimates declining from 3.4 to 2.8. This would suggest that diabetes or some correlates of it (i.e. specific dietary patterns of diabetics) (Levi et al., 1993) has some independent effect on endometrial cancer risk (Nyholm et al., 1989) . The association with liver cancer could find some biological explanation in changes in hepatocellular activity and, perhaps, mitosis, related to the metabolic alterations in diabetics. Alternatively, diabetes may be seen as a consequence of impaired liver function. History of hepatitis and cirrhosis, also associated to the risk of hepatocellular carcinoma, could not, however, totally explain the association (La Vecchia et al., 1990a) . Further, the time pattern of risk is mconsistent with this hypothesis, since the liver cancer risk remained elevated several years after diagnosis of diabetes.
In conclusion, therefore, this integrated series of studies, while showing no generalised increased cancer nrsk among diabetics, confirmed an association between diabetes and endometrial cancer, and further indicated a relationship between diabetes and liver cancer. A short-term relationship between diabetes and pancreatic cancer was also observed, but was consistent with early symptoms of pancreatic disease being related both to diabetes and pancreatic neoplasm.
